Top Markets
Coin of the day
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.

BPTH
Classificação em ações #39844
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on... Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.
Preço da ação
$0.035
Última sincronização: 2026-08-13
Valor de mercado
$326.98K
Variação (1 dia)
-12.50%
Variação (1 ano)
-74.55%
País
US
Negociar Bio-Path Holdings, Inc. (BPTH)

Categoria

Histórico de preços das ações de Bio-Path Holdings, Inc. (BPTH)
Preço de fecho mais alto: $0.04 em 2026-08-01

Preço de fecho mais baixo: $2.50K em 2006-02-01
Histórico de preços das ações da Bio-Path Holdings, Inc. de 2006 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -9.36%
2025 -91.80%
2024 -91.13%
2023 -66.41%
2022 -65.24%
2021 16.03%
2020 -52.69%
2019 59.95%
2018 -88.85%
2017 -82.76%
2016 -18.86%
2015 -40.35%
2014 -11.72%
2013 803.53%
2012 3.58%
2011 -14.96%
2010 -14.88%
2009 4.80%
2008 -52.90%
2007 18.00%
2006 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.27%
KR
$259.89 14.81%
BE